Phase I and Dose-Expansion Study of Ibrutinib and R-da-EPOCH for Front Line Treatment of AIDS-Related Lymphomas
Phase of Trial: Phase I
Latest Information Update: 21 Nov 2018
At a glance
- Drugs Ibrutinib (Primary) ; Cyclophosphamide; Doxorubicin; Etoposide; Filgrastim; Prednisone; Rituximab; Vincristine
- Indications Diffuse large B cell lymphoma
- Focus Adverse reactions
- 31 Aug 2018 Biomarkers information updated
- 14 Nov 2017 Planned End Date changed from 1 May 2019 to 18 Sep 2020.
- 14 Nov 2017 Planned primary completion date changed from 1 May 2019 to 18 Sep 2020.